BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ji J, Sundquist J, Sundquist K. Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden. Int J Cancer 2018;142:2003-10. [PMID: 29270993 DOI: 10.1002/ijc.31228] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Jebelli A, Baradaran B, Mosafer J, Baghbanzadeh A, Mokhtarzadeh A, Tayebi L. Recent developments in targeting genes and pathways by RNAi-based approaches in colorectal cancer. Med Res Rev 2021;41:395-434. [PMID: 32990372 DOI: 10.1002/med.21735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Sun L, Gao Z, Luo L, Tan H, Zhang G. Estrogen affects cell growth and IGF-1 receptor expression in renal cell carcinoma. Onco Targets Ther 2018;11:5873-8. [PMID: 30271170 DOI: 10.2147/OTT.S172149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Simin J, Khodir H, Fornes R, Tamimi RM, Brusselaers N. Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study. Acta Oncol 2022;:1-9. [PMID: 35129052 DOI: 10.1080/0284186X.2022.2033316] [Reference Citation Analysis]
4 Ray AL, Nofchissey RA, Khan MA, Reidy MA, Lerner MR, Wu X, Guo S, Hill SL, Weygant N, Adams SF, Castillo EF, Berry WL, Stout MB, Morris KT. The role of sex in the innate and adaptive immune environment of metastatic colorectal cancer. Br J Cancer 2020;123:624-32. [PMID: 32451467 DOI: 10.1038/s41416-020-0913-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Huang W, Sundquist J, Sundquist K, Ji J. Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer. Nat Commun 2020;11:3191. [PMID: 32581298 DOI: 10.1038/s41467-020-17028-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Nam JH, Jang SI, Park HS, Kim JH, Lee JK, Lim YJ, Koh MS, Lee JH, Park S, Nam CM, Park EC. The effect of menopausal hormone therapy on gastrointestinal cancer risk and mortality in South Korea: a population-based cohort study. BMC Gastroenterol 2021;21:440. [PMID: 34814853 DOI: 10.1186/s12876-021-02021-y] [Reference Citation Analysis]
7 Heo JW, Kim SE, Sung MK. Sex Differences in the Incidence of Obesity-Related Gastrointestinal Cancer. Int J Mol Sci 2021;22:1253. [PMID: 33513939 DOI: 10.3390/ijms22031253] [Reference Citation Analysis]
8 Simin J, Liu Q, Wang X, Fall K, Williams C, Callens S, Engstrand L, Brusselaers N. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study. Acta Oncol 2021;60:881-7. [PMID: 33861686 DOI: 10.1080/0284186X.2021.1909747] [Reference Citation Analysis]
9 Huang W, Sundquist J, Sundquist K, Ji J. Use of Phosphodiesterase 5 Inhibitors Is Associated With Lower Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms. Gastroenterology 2019;157:672-681.e4. [PMID: 31103628 DOI: 10.1053/j.gastro.2019.05.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
10 Kyrø C, Frederiksen K, Holm M, Nørskov NP, Knudsen KEB, Overvad K, Tjønneland A, Olsen A. Prediagnosis plasma concentrations of enterolactone and survival after colorectal cancer: the Danish Diet, Cancer and Health cohort. Br J Nutr 2019;122:552-63. [DOI: 10.1017/s0007114518002143] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 McMenamin Ú, Hicks B, Hughes C, Murchie P, Hippisley-Cox J, Ranger T, Coupland C, Cardwell C. Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales. BMC Cancer 2021;21:313. [PMID: 33761919 DOI: 10.1186/s12885-021-08065-3] [Reference Citation Analysis]
12 Ji J, Sundquist J, Sundquist K. Use of terbinafine and risk of death in patients with prostate cancer: A population‐based cohort study. Int J Cancer 2019;144:1888-95. [DOI: 10.1002/ijc.31901] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Poudou C, Baffet H, Nadeau C, Rolland AL, Catteau-Jonard S, Robin G. [Benefit-risk balance of hormone replacement therapy: Cancers and mortality. Postmenopausal women management - CNGOF and GEMVi clinical practice guidelines]. Gynecol Obstet Fertil Senol 2021;49:462-73. [PMID: 33771739 DOI: 10.1016/j.gofs.2021.03.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ranger TA, Burchardt J, Clift AK, Mei WX, Coupland C, Tan PS, Dixon S, Cardwell CR, Hippisley-Cox J. Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper. BMJ Open 2021;11:e046701. [PMID: 34341043 DOI: 10.1136/bmjopen-2020-046701] [Reference Citation Analysis]
15 Jang YC, Huang HL, Leung CY. Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis. BMC Cancer 2019;19:1199. [PMID: 31818262 DOI: 10.1186/s12885-019-6428-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]